Cargando…
Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer
The median age of cervical cancer (CC) presentation coincides with the mean age of menopause presentation (49 years) in Mexico. Here, we investigated the association between different HPV16 variants and early (≤ 49 years) or delayed (≥ 50 years) CC presentation. We conducted a case-case study that i...
Autores principales: | Alfaro, Ana, Juárez-Torres, Eligia, Medina-Martínez, Ingrid, Mateos-Guerrero, Norma, Bautista-Huerta, Maura, Román-Bassaure, Edgar, Villegas-Sepúlveda, Nicolás, Berumen, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201311/ https://www.ncbi.nlm.nih.gov/pubmed/28036379 http://dx.doi.org/10.1371/journal.pone.0169315 |
Ejemplares similares
-
The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer
por: Guardado-Estrada, Mariano, et al.
Publicado: (2014) -
The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients
por: Bolaños‐Suárez, Verónica, et al.
Publicado: (2023) -
Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
por: Medina-Martinez, Ingrid, et al.
Publicado: (2014) -
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
por: Barrón, Eira Valeria, et al.
Publicado: (2015) -
Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
por: Espinosa, Ana María, et al.
Publicado: (2013)